Post COVID-19 persistent symptoms and functional status in COVID-19 survivors: a multi-center study

Amal Mahmoud Ibrahim Goda, Osama Amin Abd Elhamid Ahmed, Ahmed Moustafa Abdel Samad Wedn, Ayat F. Manzour
{"title":"Post COVID-19 persistent symptoms and functional status in COVID-19 survivors: a multi-center study","authors":"Amal Mahmoud Ibrahim Goda, Osama Amin Abd Elhamid Ahmed, Ahmed Moustafa Abdel Samad Wedn, Ayat F. Manzour","doi":"10.1186/s43168-024-00309-7","DOIUrl":null,"url":null,"abstract":"Post COVID symptoms are a series of chronic symptoms that patients may experience after resolution of acute COVID-19. Different post-COVID-19 condition phenotypes might exist, although exact causes, management, and outcomes are not known. To assess the functional status among post-COVID-19 survivors and identify the associated socio-demographic, clinical, and laboratory risk factors of the poor functional status among those cases and to identify the most common persistent symptoms among post-COVID-19 survivors after discharge. This was a cross-sectional study conducted on 150 recovered cases who had been infected with COVID-19 as confirmed by swab during hospitalization and being interviewed regarding functional status 6 months post-hospital discharge. Cases were divided into two groups: the decreased functional status group (n = 74) and the non-decreased functional status group (n = 76). The present study indicated statistically significant differences between the studied groups; receiving the influenza vaccine was significantly associated with keeping the pre-COVID functional status (p = 0.02). The reduced functional status group had a significantly more severe disease course, prolonged hospital as well as ICU stay (p < 0.001), and worse CT findings than the normal functional status group (p = 0.004). Long-term symptoms such as headache, mood changes, insomnia, hearing problems, dry eyes, breathlessness, and chest tightness were significantly more prevalent among those who reported limitations in their functional status (p < 0.001). There were significantly higher CRP, serum ferritin, and D-dimer in the reduced functional status group. The present study highlights that most COVID-19 recovered cases have different degrees of functional limitations ranging from null to severe based on the PCFS scale. These limitations were affected by periodic influenza vaccination, ICU admission, and length of hospital stay. Some laboratory parameters were associated with reduced functionality: CRP, D-dimer, and serum ferritin. Psychological/neurological symptoms and breathlessness were significantly associated with reduced PCFS. This calls for public health action and necessitates widespread health education of post-COVID-19 health consequences.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian Journal of Bronchology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s43168-024-00309-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Post COVID symptoms are a series of chronic symptoms that patients may experience after resolution of acute COVID-19. Different post-COVID-19 condition phenotypes might exist, although exact causes, management, and outcomes are not known. To assess the functional status among post-COVID-19 survivors and identify the associated socio-demographic, clinical, and laboratory risk factors of the poor functional status among those cases and to identify the most common persistent symptoms among post-COVID-19 survivors after discharge. This was a cross-sectional study conducted on 150 recovered cases who had been infected with COVID-19 as confirmed by swab during hospitalization and being interviewed regarding functional status 6 months post-hospital discharge. Cases were divided into two groups: the decreased functional status group (n = 74) and the non-decreased functional status group (n = 76). The present study indicated statistically significant differences between the studied groups; receiving the influenza vaccine was significantly associated with keeping the pre-COVID functional status (p = 0.02). The reduced functional status group had a significantly more severe disease course, prolonged hospital as well as ICU stay (p < 0.001), and worse CT findings than the normal functional status group (p = 0.004). Long-term symptoms such as headache, mood changes, insomnia, hearing problems, dry eyes, breathlessness, and chest tightness were significantly more prevalent among those who reported limitations in their functional status (p < 0.001). There were significantly higher CRP, serum ferritin, and D-dimer in the reduced functional status group. The present study highlights that most COVID-19 recovered cases have different degrees of functional limitations ranging from null to severe based on the PCFS scale. These limitations were affected by periodic influenza vaccination, ICU admission, and length of hospital stay. Some laboratory parameters were associated with reduced functionality: CRP, D-dimer, and serum ferritin. Psychological/neurological symptoms and breathlessness were significantly associated with reduced PCFS. This calls for public health action and necessitates widespread health education of post-COVID-19 health consequences.
COVID-19 后幸存者的持续症状和功能状态:一项多中心研究
COVID-19 后症状是急性 COVID-19 病情缓解后患者可能出现的一系列慢性症状。可能存在不同的 COVID-19 后症状表型,但其确切原因、管理和结果尚不清楚。目的:评估 COVID-19 后幸存者的功能状况,确定导致这些病例功能状况不佳的相关社会人口、临床和实验室风险因素,并确定 COVID-19 后幸存者出院后最常见的持续症状。这是一项横断面研究,研究对象是 150 名康复病例,他们在住院期间通过拭子确认感染了 COVID-19,出院后 6 个月接受了有关功能状况的访谈。病例被分为两组:功能状态下降组(74 人)和功能状态未下降组(76 人)。本研究表明,研究组之间存在显著的统计学差异;接种流感疫苗与保持 COVID 前的功能状态显著相关(p = 0.02)。与正常功能状态组相比,功能减退组的病程明显更长,住院时间和重症监护室停留时间更长(p < 0.001),CT结果更差(p = 0.004)。在报告功能状态受限的患者中,头痛、情绪变化、失眠、听力问题、眼睛干涩、呼吸困难和胸闷等长期症状的发生率明显更高(P < 0.001)。功能状态下降组的 CRP、血清铁蛋白和 D-二聚体明显更高。本研究强调,根据 PCFS 量表,大多数 COVID-19 康复病例都有不同程度的功能受限,从无到严重不等。这些功能限制受到定期接种流感疫苗、入住重症监护室和住院时间的影响。一些实验室参数与功能减退有关:CRP、D-二聚体和血清铁蛋白。心理/神经症状和呼吸困难与 PCFS 的降低有显著相关性。这就要求采取公共卫生行动,并有必要就COVID-19后的健康后果开展广泛的健康教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信